Child Cancer Survival Imperiled by Lack of New Drugs

Improving childhood cancer survival rates is being stymied by regulatory burdens and stagnant research approaches, U.S. and European doctors said.

Read more here.

Targeting specific protein regions offers a new treatment approach in medulloblastoma

A new era for treating high-risk neuroblastoma – research advances to look out for in 2024

FDA approves tovorafenib for most common form of childhood brain tumor

‘Kinder’ treatment for childhood brain cancer to be offered by NHS in England

New findings regarding diabetes risk in childhood cancer survivors

What it’s like to be a ‘glass child’

Childhood cancer survivors face ‘numerous socioeconomic challenges’

Groundbreaking treatment approach shows promise in hard-to-treat cancers

Neuroblastoma study identifies new subgroups with distinct prognoses and potential vulnerabilities to therapies

PET/MRI detects brain injury in pediatric cancer survivors